One Day MD | Evidence-Based Wellness

The landscape of weight management underwent a permanent evolution when metabolic health guidelines shifted away from standard calorie-counting diets toward advanced anti-obesity medications (AOMs). Today, achieving sustainable health is no longer about raw numbers on a scale; it is about achieving quality weight loss—reducing dangerous visceral fat while fiercely protecting critical skeletal muscle tissue.   The Intracellular Mechanics of Satiety Modern options like semaglutide and tirzepatide work by mimicking natural incretin hormones. When these medications bind to the GLP-1 Receptor on a cellular level, they spark an intracellular chain reaction. This triggers an increase in cyclic adenosine monophosphate ( cAMP ), which activates downstream master signaling path networks like mTOR and PI3K . The result is a dual benefit: the pancreas optimizes glucose-dependent insulin secretion via GLUT pathways, while the brain receives a prolonged signal of full satisfaction, ...

By AI Health Editorial Board | Deep-Dive Market & Clinical Audit | Published: July 2026   Key Executive Insights Record Adoption: A landmark July 2026 Gallup poll reveals that 11% of U.S. adults are currently taking GLP-1 drugs for weight loss, driving a historic decline in national obesity to 36.4%. Institutional Shift: On July 1, 2026, CMS officially rolled out the Medicare GLP-1 Bridge program, granting qualifying beneficiaries access to tier-1 brand treatments for a low $50 monthly copay. The Compounding Dilemma: High commercial retail prices have forced 19% of active users onto non-FDA-approved compounded alternatives, introducing substantial risks regarding dosing, labeling, and structural uniformity. The Scientific Trap: New clinical trials demonstrate that an inconsistent, "stop-and-start" pattern due to cost or supply gaps hits a biological "muscle floor"—triggering rapid fat regain and permanently blunting...

Scientific Review & Regulatory Audit by the Clinical Editorial Team The therapeutic paradigm for progressive neurodegenerative disorders like Parkinson’s disease (PD) and various forms of dementia faces a critical bottleneck. Standard pharmacology, primarily anchored by levodopa (L-DOPA) for Parkinson’s and acetylcholinesterase inhibitors for dementia, remains strictly symptomatic. These options frequently suffer from diminishing efficacy and significant side-effect profiles like L-DOPA-induced dyskinesia over long-term use. Consequently, the pharmaceutical community has focused heavily on drug repurposing—identifying established, safety-vetted compounds capable of crossing pathways to modify disease progression. An unexpected frontline candidate emerging in this space is ivermectin. Traditionally classified as a broad-spectrum antiparasitic agent, a surge of preclinical studies between 2020 and 2024 has unveiled its complex, multi-targeted pharmacodynamics within the mam...

Quick Answer: In 2026, US consumers can access premium biological age kits directly online without a primary doctor's prescription. GlycanAge measures chronic systemic inflammation via IgG immune structures and is fully HSA/FSA eligible. TruDiagnostic's TruAge Complete utilizes advanced DNA methylation algorithms (like DunedinPACE) to track cellular aging speeds. While both offer seamless domestic shipping, TruAge may require a Letter of Medical Necessity (LMN) for tax-account reimbursement depending on your specific benefits administrator. Your birth certificate tells you your chronological age, but it says nothing about your cellular reality. If you are actively practicing metabolic therapies, cycling longevity supplements (like NAD+ precursors or senolytics), or maintaining a strict lifestyle intervention, tracking your biological age is the only objective way to verify if your daily habits are working or if you are accelerating systemic decline. In ...

Xylitol is one of the most extensively studied sugar alcohols for oral health. Unlike regular sugar, it cannot be effectively metabolized by the primary bacteria responsible for dental caries (cavities), making it a valuable adjunct to good oral hygiene. What is Xylitol? Xylitol is a naturally occurring sugar alcohol found in small amounts in fruits, vegetables, and hardwood trees such as birch. It has approximately the same sweetness as sucrose but contains about 40% fewer calories . Unlike sugar, xylitol has a very low glycemic index and does not promote acid production by oral bacteria. How Xylitol Prevents Dental Caries 1. Reduces cavity-causing bacteria The major bacterium associated with dental caries is Streptococcus mutans. Normally: Sugar → bacteria ferment it Acid is produced Tooth enamel demineralizes Cavities develop With xylitol: Bacteria take up xylitol They cannot efficiently metabolize it Energy is wasted ...

Microplastics (particles <5 mm) and nanoplastics (typically <1 μm) are increasingly recognized as potential disruptors of mitochondrial function. Mitochondria produce over 90% of the body's ATP (energy), regulate oxidative stress, control apoptosis (programmed cell death), and influence immune responses. Experimental research suggests that microplastics can impair many of these functions, although evidence in humans remains limited. How Microplastics Reach Mitochondria Humans are exposed through: Food and drinking water Seafood Airborne dust Plastic food packaging Synthetic textiles Personal care products While larger microplastics are less likely to enter cells, nanoplastics can cross biological barriers, enter cells through endocytosis, and accumulate in organelles, including mitochondria in laboratory models. Mechanisms of Mitochondrial Damage 1. Excessive Reactive Oxygen Species (ROS) One of the earliest effects observed is increased mitochondri...

A comprehensive, peer-reviewed synthesis of preclinical and clinical evidence for H₂ therapy across 20 disease categories — 2026 Update Published: June 2026 Last Reviewed: June 2026   2026 Update References: 160+ citations Category: Integrative Medicine | Antioxidant Therapy Reading Time: ~18 min Peer-Reviewed Format Abstract Molecular hydrogen (H₂) has emerged over the past two decades as a uniquely versatile therapeutic agent, distinguished by its ability to selectively scavenge cytotoxic reactive oxygen species (ROS) while crossing all biological barriers, including the blood-brain barrier. Since the landmark 2007 Nature Medicine publication, more than 5,000 papers and over 100 registered clinical trials have examined H₂ across conditions spanning neurodegeneration, cancer, cardiovascular disease, metabolic syndrome, inflammatory disorders, and respiratory illness. This updated review synth...